Adjunctive therapy to antidepressants for MDD ( 2.5)
1.5 mg daily
1.5 mg or 3 mg daily
* Schizophrenia and Bipolar Mania: Maximum recommended daily dosage is 6 mg. Dosages above 6 mg daily do not confer significant benefit, but increase the risk of dose-related adverse reactions ( 2.2, 2.3)
* Bipolar Depression: Maximum recommended daily dosage is 3 mg ( 2.4)
* Adjunctive therapy for treatment of MDD: Maximum recommended daily dosage is 3 mg ( 2.5)
Get Your Patient on Vraylar
See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form